Table 3.
Authors | Year of publication | Gender | Age at GBS Onset | Delay between UC onset and GBS | Treatment received before GBS onset | UC activity | Clinical features of GBS | Albuminocytologic dissociation | GBS electrophysiological form | GBS treatment | Outcome | Ref. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Torre RG et al. | 2010 | Male | 74 | GBS was inaugural preceded IBD onset by 2 months | None | Active with tuberculosis | Paraparesis | Absent | Axonal | IVIG | Partial improvement | [11] |
2 | Zimmerman J et al. | 1985 | Female | 65 | 18 months | Sulfasalazine and oral corticosteroids | Remission | Tetraparesis Urinary disturbances Facial diplegia Dysphagia |
Present | Demyelinating | Corticosteroids | Complete recovery | [12] |
3 | Male | 58 | 12 years | Sulfasalazine | Remission | Areflexia Paraparesis Limb hypoesthesia Respiratory failure |
Absent | Demyelinating | Corticosteroids | Complete recovery | |||
4 | Krystallis CS et al. | 2009 | Male | 59 | 5 years | 5 aminosalicylate | Active | Limb paresthesia | Present | Demyelinating | IVIG | Complete recovery | [13] |
5 | Liu Z et al. | 2018 | Male | 31 | 3 months | Mesalazine + 5 aminosalicylate | Active | Quadriparesis | Present | Axonal | IVIG | Partial improvement | [14] |
6 | Saito M et al. | 1994 | Female | 56 | NA | 5 aminosalicylate | Active with Rubella infection | Quadryparesis | NA | NA | Plasmapharesis | Complete recovery | [15] |
7 | Roca B et al. | 1999 | Female | 69 | 30 years | 5 aminosalicylate | Remssion Mild upper respiratory infection |
Quadriparesis | Present | Demyelinating | IVIG | Complete recovery | [16] |
8 | Tominaga K et al. | 2019 | Male | 39 | GBS was inaugural and preceded IBD onset by 2 weeks | Was not yet under treatment | Active | Quadriparesis Unilateral VI and VII nerve paresis |
Absent | Axonal | IVIG | Complete recovery | [17] |
9 | Bouchra A et al. | 2009 | Female | 47 | 10 years | 5 aminosalicylate | Remission | Quadriparesis | present | Axonal | IVIG | Partial improvement | [18] |
10 | Jayasundara et al. | 2022 | Male | 24 | 2 years | None | Concomittent flare-up | Paraparesis areflexia | Present | NA | IVIG | Partial improvement | [19] |
11 | Our case | Female | 30 | 4 months | Azathioprine | Active with SARS-CoV-2 infection | Quadriparesis | Absent | Axonal | IVIG | Partial improvement |
IBD: Inflammatory bowel disease; IVIG: Intravenous immunoglobulin; NA: Not available; GBS: Guillain–Barré syndrome; UC: Ulcerative colitis.